Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Russian HIV initiatives get further $24m

This article was originally published in Clinica

Executive Summary

A Russian HIV/AIDS programme that has been built up over the last five years with the support of an $89m grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria has received the funding needed to operate for a further two years. The Global Fund has approved an additional $24m to fund the programme until the end of 2011. The prevention programme, described by the Global Fund as "successful", is targeted at "highly vulnerable" groups, and runs across the country's 83 administrative regions. An estimated 1 million people are infected with HIV in Russia. The government has contributed $226m to the Global Fund, and supports other initiatives nationally.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT044815

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel